'Zero Window'by ClearVue and LuxWall |
|
ClearVue partnered with a leading US vacuum insulated glazing supplier LuxWall Inc. to develop a ‘Zero Window’™ - the most energy-efficient and energy-generating window on the market, helping the construction sector meet net-zero targets. ClearVue and LuxWall have commenced work on the prototype of which we are eager to demonstrate at the AIA24 Conference on Architecture and Design in Washington DC, USA in June 2024. READ MORE |
|
|
Generation2 Glazing on the Facade |
|
Our first commercial order for the Generation 2 product to be used in the façade of the Construction, Forestry, Maritime, and Employees Union Training and Wellness Centre in Melbourne. Our technology's sustainability benefits and high performance were recognized by award-winning Australian architect Hayball, who specified the product from the outset, aiming for a 5-Star GreenStar and a Gold WELL certification. The construction has commenced, and ClearVue solar glass installation is scheduled for April 2024. We cannot wait to share the project's progress with you. READ MORE |
|
|
Charles Mowrey's Presentation |
|
Our non-executive director Charles Mowrey, a CEO of 8G Solutions, visited us in Perth and attended a 2023 AGM, where he delivered an insightful presentation, explaining the impact of ClearVue Solar Glazing on the façade and fenestration industry. If you weren't able to attend live, you now have the opportunity to watch it at your convenience. WATCH VIDEO |
|
|
We are currently engaged with over 50 projects around the globe, and we are seeing great interest from the North American market, Europe, Asia and Australia.
“We are progressing with multiple discussions at the moment, but the time span between the project planning and the contract can be extensive. We are confident that a number of these discussions will evolve into contracts, but we understand the process may extend over several weeks or even months. The contract with the CFMEU Wellness Centre is a positive indicator, and we anticipate a growing adoption of our product locally and globally”, says Chief Business Development Officer Clifton Smyth. |
|
|
$1.725 Million At-The-Market RaiseIn January, ClearVue raised via the ATM $1.725 million (before fees) at a 6.7% premium above the 15-day Volume Weighted Average Price. These funds will support our growth plans. |
|
We are actively expanding our global network of solar IGU manufacturers and distributors to facilitate product delivery to our customers. This is a pivotal aspect of our strategy, and we’ve recently established new partnerships in key regions: with the first Australian manufacturer MS Glass, H T Glass in Singapore, 8G Solutions in the US, and a distributor in South Africa.
We are currently engaged in discussions with more than five partners across Europe, the Middle East and India, with expectations of formalizing these collaborations in the coming months. |
|
|
Our new and existing licensee partners have received the initial shipment of the ClearVue technology components and are currently building the Generation2 Solar IGUs for internal testing. This phase is crucial as it validates the production process and ensures a seamless transition into full-scale commercial manufacturing. |
|
George Thomas, our Business Development Consultant, showcased the ClearVuePV Solar Glazing solution at the prestigious Facades+ conference in Seattle in December 2023. Alongside leading professionals in construction, design, and engineering, he actively participated in the Transforming the Energy Grid: Photovoltaic Facades and On-Site Storage roundtable discussion, delving into high-performance envelope solutions. |
|
|
FORWARD LOOKING STATEMENTS |
|
|
Statements contained in this newsletter, particularly those regarding possible or assumed future performance, revenue, costs, dividends, production levels or rates, prices or potential growth of ClearVue Technologies Limited, are, or may be, forward looking statements. Such statements relate to future events and expectations and, as such, involve known and unknown risks and uncertainties. Actual results and developments may differ materially from those expressed or implied by these forward-looking statements depending on a variety of factors. |
|
|
(20min delay)